Bill
Bill > HR2851
US HR2851
SITSA Act Stop the Importation and Trafficking of Synthetic Analogues Act of 2017
summary
Introduced
06/08/2017
06/08/2017
In Committee
07/12/2017
07/12/2017
Crossed Over
06/18/2018
06/18/2018
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
SITSA Act Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 This bill amends the Controlled Substances Act to establish a new, sixth schedule of controlled substances—schedule A. A drug or substance in schedule A has a chemical structure that is similar to, and an effect on the body that is similar to or greater than, a controlled substance in schedule I, II, III, IV, or V. The bill adds 13 synthetic fentanyl-related substances to schedule A. It also authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently place a drug or substance in schedule A. The bill establishes criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute a schedule A substance. However, it explicitly prohibits criminal and civil penalties solely for possession of a schedule A controlled substance. The bill makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a schedule A substance that is not clearly labeled. Finally, it establishes new, separate DEA registration requirements for manufacturers, distributors, and importers and exporters of schedule A substances.
AI Summary
This bill, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017, establishes a new Schedule A under the Controlled Substances Act for substances that are chemically similar to and have effects similar to or greater than controlled substances in Schedules I-V. The bill authorizes the Attorney General to temporarily and permanently place substances in Schedule A, and creates new criminal penalties for the importation, exportation, manufacture, distribution, or possession with intent to distribute of Schedule A substances. The bill also requires special registration for the manufacture, distribution, importation, and exportation of Schedule A substances, and prohibits the false labeling of such substances.
Committee Categories
Business and Industry, Health and Social Services, Justice
Sponsors (76)
John Katko (R)*,
Lou Barletta (R),
Mike Bishop (R),
Diane Black (R),
Marsha Blackburn (R),
Mike Bost (R),
Susan Brooks (R),
Vern Buchanan (R),
Ted Budd (R),
Bradley Byrne (R),
Steve Chabot (R),
Chris Collins (R),
Barbara Comstock (R),
Ryan Costello (R),
Kevin Cramer (R),
Carlos Curbelo (R),
John Curtis (R),
Scott DesJarlais (R),
Mario Diaz-Balart (R),
Daniel Donovan (R),
Blake Farenthold (R),
John Faso (R),
Brian Fitzpatrick (R),
Chuck Fleischmann (R),
Mike Gallagher (R),
Vicente Gonzalez (D),
Bob Goodlatte (R),
Josh Gottheimer (D),
Trey Gowdy (R),
Karen Handel (R),
Andy Harris (R),
Vicky Hartzler (R),
Evan Jenkins (R),
Dave Joyce (R),
Mike Kelly (R),
Peter King (R),
Stephen Knight (R),
Frank LoBiondo (R),
Thomas MacArthur (R),
Tom Marino (R),
Brian Mast (R),
Michael McCaul (R),
David McKinley (R),
Martha McSally (R),
Patrick Meehan (R),
Paul Mitchell (I),
Alex Mooney (R),
Grace Napolitano (D),
Richard Neal (D),
Ralph Norman (R),
Pete Olson (R),
Scott Perry (R),
Tom Reed (R),
Kathleen Rice (D),
David Roe (R),
Thomas Rooney (R),
Keith Rothfus (R),
David Rouzer (R),
John Rutherford (R),
F. James Sensenbrenner (R),
Pete Sessions (R),
Bill Shuster (R),
Kyrsten Sinema (I),
Lamar Smith (R),
Lloyd Smucker (R),
Elise Stefanik (R),
Steve Stivers (R),
Tom Suozzi (D),
Claudia Tenney (R),
G.T. Thompson (R),
Mike Turner (R),
Fred Upton (R),
Filemón Vela (D),
Greg Walden (R),
Ted Yoho (R),
Lee Zeldin (R),
Last Action
Received in the Senate and Read twice and referred to the Committee on the Judiciary. (on 06/18/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...